Back to NVSEFView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
View Full LandscapeDrug Information
Target Indication
Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
Clinical Trial
NCT00961896Last updated: 3/11/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
FingolimodPhase 3
Multiple Sclerosis
dovitinibPhase 3
Solid Tumors
MF59-eH1N1_fPhase 3
Influenza
Glycopyrronium bromidePhase 3
Chronic Obstructive Pulmonary Disease
Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccinePhase 3
Swine-Origin Influenza A H1N1 Virus
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts